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Summary. The aim of the present study was to
characterise the expression pattern of claudin-1, -3, -4, 
-5 and -7 tight junction proteins in canine normal
colorectum and in the low-grade, tubulopapillary
colorectal carcinoma in canines. Methods and results:
The biopsy samples included 10 canine normal
colorectal tissues and 20 canine low grade colorectal
carcinomas (CLGCCs). The canine normal colorectal
mucosa was negative for claudin-1. Claudin-1 was
detected as a non-diffuse intense membrane labelling of
neoplastic epithelial cells in low grade colorectal cancer
in canines. Fifty five per cent of all tumours showed a
weak cytoplasmic pattern of staining for claudin-1
protein. The normal colorectal mucosa showed diffuse
punctate positivity for claudin-3. Claudin-3 was detected
as an intense lateral membrane labelling of tumour cells
in CLGCCs. Claudin-4 expression in surface and crypt
epithelial cells of the intact colorectal mucosa in canines
was punctate. Claudin-4 molecule was detected as a
lateral membrane labelling of neoplastic cells in
CLGCCs. The epithelium of the CLGCCs and the low
grade colorectal carcinoma were negative for claudin-5.
The surface and crypt epithlial cells of the canine normal
colorectal mucosa showed a diffuse lateral membranous
pattern of staining for claudin-7. Claudin-7 molecule
was detected as an intense membrane labelling of
neoplastic cells in CLGCCs. Seventy per cent of all
tumours showed weak cytoplasmic positivity for
claudin-7. Conclusion: Consequently, we hypothesize
that claudin-1 plays a role in the progression of
CLGCCs. Further functional studies are needed to
clarify the biological role of the mislocalization of the
claudin-1 molecule from cell membrane to the
cytoplasm in CLGCCs. Lower claudin-4 expression
suggests that reduced expression of claudin-4 molecule
may lead to cellular disorientation, detachment and
invasion of CLGCCs. Further functional studies are
needed to clarify the biological role of overexpression
and mislocalisation of claudin-7 in CLGCCs.
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Introduction
Human colorectal carcinoma (HCRC) is an
important cause of death by cancer worldwide and has
variable geographical distribution. Virtually 98% of all
cancers in the large intestine are adenocarcinomas
(Jemal et al., 2002; Kinzler and Vogelstein, 2002). They
usually arise in polyps and produce symptoms relatively
early and at a stage generally curable by surgical
resection (Burgart, 2002). Major predisposing factors in
the etiopathogenesis of HCRC include the presence of
pre-malignant conditions, such as familial polyposis
syndrome, inflammatory bowel disease and dietary
factors. A diet rich in refined carbohydrate and low in
unabsorbable vegetable fibre content and fresh
vegetables, the intake of red meat, and a decreased
intake of protective micronutrients, all increase fecal
transit time (Eaden et al., 2001; Jass, 2001; Wei et al.,
2004; Kumar et al., 2005). The peak incidence for
HCRC is between ages 60 and 79 years (Kumar et al.,
2005). The histological grade of HCRCs is an important
prognostic variable and depends on the degree of
glandular differentiation and cellular polarity. High-
grade or poorly differentiated HCRC’s are usually more
aggressive than their low-grade or well differentiated
counterparts (Hermanek and Sobin, 1995).
In canines up to 60 percent of all intestinal tumours
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are located in the colon and rectum (Holt and Lucke,
1985). Colorectal carcinomas develop in older canine,
with an avarage of 8-9 years, and male canines have a
higher incidence rate than females (Schaffer and
Schieffer, 1968; Patnaik et al., 1977). Malignant
transformation of adenoma to carcinoma, observed in
humans, may be encountered in canines (Silverberg,
1971). Canine colorectal carcinoma (CCRC) can spread
in the lymphatics to lymph nodes and produces
peritoneal seeding (Brunnert et al., 1993) and distant
metastases (Stampley et al., 1987; Hampson et al.,
1990). In the veterinary oncopathology the four
categories of CCRC, namely colorectal adenocarcinoma,
mucinous adenocarcinoma, signet ring cell carcinoma,
and undifferentiated or solid carcinoma, can be divided
into two mainly histological groups: (1) low grade
CCRC, well or moderately differentiated and (2) high
grade CCRC, undifferentiated or poorly differentiated
(Head et al., 2002).
Adhesion between neighboring epithelial cells is a
crucial and tightly controlled process. In epithelial cells,
specialized structures, such as tight junctions, adherent
junctions and desmosomes are responsible for the
establishment of contacts between neighboring cells.
Claudins are key components of epithelial and
endothelial tight junctions, which act as a barrier to
paracellular flux of water, solutes, and transmigration of
other cells. There are currently at least 24 known
members of the claudin family, which are expressed in a
tissue specific pattern. These transmembrane proteins
are connected to the actin cytoskeleton via a network of
proteins, such as zonula occludens-1 (ZO-1) (Furuse et
al., 1999; Tsukita et al., 2001). In carcinogenesis, it has
been proposed that the loss of cell polarity is followed
by an abnormal influx of different growth factors, which
gives rise to auto- and paracrine stimulation of
neoplastic epithelia (Mullin, 1997). The loss of claudins
and other tight junction proteins has been suggested to
account for the loss of cell adhesion and to be an
important step in the development of tumour invasion
and metastasis (Karen et al., 2005). Several previous
studies have examined the role of claudins in human
colorectal carcinogenesis (Miwa et al., 2001; De
Oliveira et al., 2005; Dhawan et al., 2005; Resnick et al.,
2005; Grone et al., 2007; Kinguasa et al., 2007;
Nakayama et al., 2008; Oshima et al., 2008; Weber et al.,
2008).
In our previous study we described that loss or
reduction of expression of claudin-1, -2, -5 and -7 may
lead to cellular disorientation, detachment and invasion
in canine mammary neoplasia, and we deteceted a strong
expression of claudin-3 and -4 in carcinoma in situ and
grade I, II and III simple infiltrating carcinomas (Jakab
et al., 2008d). In addition to our previous studies we
investigated the microvessel density in canine mammary
gland tumours by quantitative claudin-5 molecule
immunohistochemistry (Jakab et al., 2008c), claudin-5
protein expression and localization in the normal canine
mammary gland (Jakab et al., 2008a) and neoplastic
lesions of mammary gland (Jakab et al., 2008d). 
The aim of the present study was to characterise the
expression pattern of claudin-1, -3, -4, -5 and -7 tight
junction proteins in canine normal colorectum and in the
low-grade, tubulopapillary colorectal carcinoma in
canines. The hypothesis of the present study was that
similarly to mammary gland carcinomas (Jakab et al.,
2008d), in the case of CLGCCs there is a change in the
expression pattern of the claudin proteins, which could
facilitate the detachment and cellular disorientation and
invasiveness of these tumours. We also wanted to
investigate whether colorectal epithelial cells and
CLGCC cells express claudin-5 endothel-specific
protein, and whether it could be used for microvessel
density assessment. To our knowledge, this is the first
study that has examined claudin-1, -3, -4, -5 and -7
molecule expression in canine normal colorectum and
low-grade colorectal cancer.
Materials and methods
Samples of canine tumours
Tissue samples were collected between 2005 and
2008 at Szent István University, Faculty of Veterinary
Science, Department of Pathology and Forensic
Veterinary Medicine (Budapest, HU). The samples
included 10 canine normal colorectal tissue samples and
20 canine low grade colorectal carcinoma (CLGCC).
Samples were fixed in 8% neutral buffered formalin for
24 hours at room temperature, dehydrated in a series of
ethanol and xylene, and embedded in paraffin. The 3-4
µm thick sections were routinely stained with
hematoxylin and eosin (HE). Each neoplastic case was
classified by the pathologists (CSJ and JK) according to
grade (Greene et al., 2002) (Fig. 1A-D).
Immunohistochemistry
Serial sections (3-4 µm) were initially dewaxed in
xylene and graded ethanol. After treatment with
appropriate antigen retrieval (Target Retrieval Soluton,
DAKO, Glostrup, Denmark, pH 6; microwave - 800W -
oven for 30 min), the sections were incubated with
primary antibodies against claudin-1 (rabbit polyclonal,
diluted 1 in 100), claudin-3 and claudin -7 (both rabbit
polyclonal and diluted 1 in 80), claudin-4 and claudin-5
(both mouse monoclonal and diluted 1 in 100) for 60
min at room temperature. All primary antibodies were
from Zymed Inc., San Francisco, CA, USA.
Immunohistochemical labelling was performed using the
streptavidin-peroxidase procedure. Antigen-bound
primary antibody was detected using standard avidin-
biotin immunoperoxidase complex (DAKO, LSAB2
Kit). The chromogen substrate was 3, 3’-
diaminobenzidine tetrahydrochloride (DAB substrate-
chromogen, DAKO). Sections were counterstained with
Mayer’s hematoxylin. 
Negative controls were performed by omission of
the primary antibody and positive controls was canine
normal mammary gland for claudin-1, -3, -4 and -7
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(Jakab et al., 2008a,b), endothelial cells of microvessels
in canine mammary gland cancer for claudin-5 (Jakab et
al., 2008c), and canine normal mammary gland for
claudin-7 (Jakab et al., 2008a). Claudin labelling
patterns were compared with adjacent normal colonic
epithelium. The internal positive controls were the
peritumoural normal colonic epithelial tissues for
claudin-3, -4, and -7, and the endothelial cells of the
peritumoural lymphatic vessels, small arteries and veins
for claudin-5. Peritumoural fibroblasts and smooth
muscle cells served as internal negative controls since
these cells do not express claudin proteins.
Immunohistochemistry assessment
In each case, two independent observers (CSJ and
JK) recorded the distribution and intensity of labelling.
The immunoreactivity was assesed as follows: negative
(-), no immunostaining present; (+), <25% of cells
positive; (++), 25-50% of cells positive; (+++), 50-75%
of cells positive; (++++), 75-100% of cells positive.
For scoring purposes, the intensity of staining of
claudin molecules expressing neoplastic cells was
compared to that of normal colonic mucosa. Low grade
adenocarcinomas that displayed a well-localized linear
membranous staining pattern equal to that of normal
colonic mucosa were scored as 2. CCRCs showing a
more intense staining pattern than that of normal colonic
mucosa were scored as 3; and CCRCs showing a
considerably lower intensity than normal colonic mucosa
were scored as 1.
Results
The canine normal colorectal mucosa was negative
for claudin-1 (Fig. 2A). Claudin-1 was detected as a
non-diffuse intense membrane labelling of neoplastic
epithelial cells in low grade colorectal cancer in canines.
The CLGCC showed ++ claudin-1 positivity and the
tumours showed a more intense staining pattern than that
of normal colorectal mucosa (3 immunopositivity) (Fig.
2B-D). A few tumours showed (11:20; 55%) a weak
cytoplasmic pattern of staining for claudin-1 protein.
The normal colorectal mucosa showed a diffuse
punctate positivity for claudin-3 molecule. This claudin
protein localized specifically to the region of the tight
junction in surface and crypt epithelium (Fig. 3A,B).
The intact surface and crypt colonocytes did not show a
cytoplasmic positivity for claudin-3 molecule. The
claudin-3 protein was detected as an intense lateral
membrane labelling of tumour cells in low grade
colorectal cancer in canines. The CLGCC showed a
++++ positivity for claudin-3 and it showed a more
intense staining pattern than that of normal colorectal
mucosa (3 immunopositivity) (Fig. 3C-D). We did not
detect claudin-3 cytolplasmic positivity in the neoplastic
cells.
Claudin-4 expression in surface and crypt epithelial
cells of the intact colorectal mucosa from canine was
punctate, without cytoplasmic positivity and it localized
specifically to the region of the tight junction, like
claudin-3 protein. Claudin-4 molecule was detected as a
lateral membrane labelling of neoplastic cells in low
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Fig. 1. Canine low grade colorectal
carcinoma. Tubular and tubulopapillary
adeno-carcinoma in the colorectum of
the canine show irregular branching
tubules and papil lary projections
embedded in a moderate amount of
fibrous stroma. In the pictures some
mitotic neoplastic cells can be seen. A-
C, x 200; D, x 400 
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Fig. 2. A. The canine normal
colorectal mucosa was
negative for claudin-1 protein.
B. Increased claudin-1
expression in the canine low
grade colorectal carcinoma.
C. On the right hand side of
the picture normal, claudin-1
negative glands of canine
colorectum and on the left
hand side claudin-1 positive
canine low grade colorectal
cancer can be seen. D.
Similar picture at higher
magnification A, C, x 200; B,
D, x 400
Fig. 3. A-B. The canine
normal colorectal mucosa
showed a diffuse punctate
posit ivity for claudin-3
molecule. C-D. A strong
diffuse membranous claudin-
3 expression in canine low
grade colorectal cancer A, x
200; B-D, x 400
grade colorectal cancer in canines. The CLGCC showed
+++ positivity for claudin-4 and the low grade
carcinomas showed an equally intense staining pattern
when compared with normal colorectal mucosa (2
immunopositivity). We did not detect claudin-4
cytolplasmic positivity in the tumour cells.
The epithelium of the canine normal colorectal
mucosa and the CLGCC were negative for claudin-5, but
the endothelial cells of the normal vessels, lymphatics
and the intra- and peritumoural tumoural microvessels
showed intense claudin-5 positivity.
The surface and crypt epithlial cells of the canine
normal colorectal mucosa showed a diffuse lateral
membranous pattern of staining for claudin-7, without
cytoplasmic positivity (Fig. 4A-B). Claudin-7 molecule
was detected as an intense membrane labelling of
neoplastic cells in low grade colorectal cancer in
canines.
The CLGCC showed ++++ positivity for claudin-7
and the low grade carcinomas showed an equally intense
staining pattern when compared with normal colorectal
mucosa (2 immunopositivity) (Fig. 4C-D). Seventy
percent of all tumour samples (14:20) showed weak
cytoplasmic positivity for the claudin-7 protein.
Discussion
In epithelial cells, specialized structures, such as
tight junctions and adherent junctions are responsible for
the establishment of contacts between neighboring cells.
Claudins are key components of epithelial and
endothelial tight junctions, which act as a barrier to
paracellular flux of water, solutes, and transmigration of
other cells. Claudins are responsible for the formation of
tight junction strands, and the second function of these
proteins is the preservation of cell polarity in the
epithelial and endothelial barriers (Furuse et al., 1999;
Tsukita et al., 2001). Within tight junctions, claudins
form homophilic and heterophilic complexes on
apposing cells (Furuse et al., 1999). These
transmembrane proteins are connected to the actin
cytosceleton via a network of proteins, such as zonula
occludens-1 (ZO-1) (Furuse et al., 1999; Tsukita et al.,
2001). Claudin proteins have been proposed to have
important roles in different biological processes,
including embryogenesis, development, tissue
remodelling, and oncogenesis. The preservation of cell
polarity and paracellular flux by many claudin molecules
suggests that these proteins contribute to tumour
suppressive functions in epithelial neoplasia. The loss of
claudins and other tight junction proteins has been
suggested to underlie the loss of cell adhesion and be an
important step in the development of tumour invasion
and metastasis (Karen et al., 2005). Claudins have been
shown to modify tumour invasion by the regulation of
matrix metalloproteinases (Miyamori et al., 2001).
In our present study we investigated the expression
of claudin-1, -3, -4, -5 and -7 tight junction proteins in
the surface and crypt epithelial cells of the canine
normal colorectal mucosa and in the neoplastic epithelial
cells of CLGCC. Ridyard et al. (2007) described
increased expression of claudin-2 by the colonic
epithelium of canines with idiopathic lymphocytic-
plasmacytic colitis.
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Fig. 4. A-B. Canine normal colorectal
mucosa showed diffuse l inear
membrane positivity for claudin-7
molecule. C-D. Strong diffuse claudin-
7 expression in canine low grade
colorectal cancer A, C, x 200; B, D, x
400 
HCRC is the second most common cause of death
by cancer (Kumar et al., 2005). Several studies have
described that claudin-1 expression is progressively
increased in human colon carcinogenesis, with the
highest expression in metastatic samples and cell lines
derived from metastatic sources (Resnick et al., 2005).
Manipulation of claudin-1 levels in colon cancer cells
showed a positive correlation between claudin-1
expression and tumour growth and metastasis (Dhawan
et al., 2005). Claudin-1 was identified as a probable
target of ß-catenin/Tcf signaling, which supports a
potential role for claudin-1 dysregulation in human
colorectal carcinogenesis (Miwa et al., 2001). Claudin-1
expression is a positive prognostic indicator and
correlates with lower tumour grade, absence of
lymphovascular invasion, and increased patient survival
(Resnick et al., 2005). Human preliminary studies, using
non-transformed RIE cells and normal colon tissue
samples observed that claudin-1 protein is not expressed.
However, it is highly expressed in colon tumour tissues
and the expression increases further in the metastatic
colon cell lines and tissue samples (Dhawan et al.,
2005). In our present study we have detected that the
epithelium of the canine normal colorectal mucosa was
negative for claudin-1 molecule, but claudin-1 was
detected as a non-diffuse intense membrane labelling of
neoplastic epithelial cells in CLGCC. We detected that
claudin-1 expression increased in the CLGCC compared
to normal mucosa. Miwa et al. (2001) reported that
claudin-1 was frequently upregulated in neoplastic tissue
when compared to normal mucosa. Our result suggests
that increased expression of claudin-1 may play an
important role in the colorectal carcinogenesis in
canines. However, in our previous study we described
that the reduction of expression of claudin-1 protein may
lead to cellular disorientation, detachment and invasion
in canine mammary neoplasia (Jakab et al., 2008d).
Further functional studies are needed to clarify the
biological role of claudin-1 expression in these
histologic subtypes of canine colorectal tumour. In the
present study a few tumours showed a weak non-
junctional, cytoplasmic pattern of staining for claudin-1
protein. A previous human study described increased
expression of claudin-1 in human colon cancers, with
mislocalization from cell membrane to the nucleus and
cytoplasm. Metastatic colon cancer cells expressed the
highest levels of claudin-1 and the highest rate of
mislocalization (Dhawan et al., 2005).
In the present study we detected a diffuse punctate
positivity for claudin-3 and claudin-4 molecules in the
epithelium of the canine normal colorectal mucosa and
overexpression of claudin-3 protein in the CLGCC.
According to a human study, normal colonic epithelium
exhibited a membranous pattern of staining for claudin-4
molecule (Resnick et al., 2005). Of note is the fact that
claudin-3 and -4 act as receptors for Clostridium
perfringens enterotoxin (CPE) (Katahira et al., 1997;
Morita et al., 1999) which is able to directly and rapidly
lyse mammalian cells (McClane et al., 1988; Kominsky
et al., 2004). 
The first endothel-specific claudin was claudin-5,
also known as transmembrane protein deleted in velo-
cardio-facial syndrome (TMVCF) (Morita et al., 1999;
Sirotkin et al., 1997). Several members of the claudin-
family, such as claudin-2 and claudin-5 are able to
activate membrane-type-1-MMP-mediated pro-MMP-2
processing (Miyamori et al., 2001). In our previous
studies we investigated the microvessel density in canine
mammary gland tumours by quantitative claudin-5
molecule immunohistochemistry (Jakab et al., 2008c),
claudin-5 protein expression and localization in the
normal canine mammary gland (Jakab et al., 2008a), and
neoplastic lesions of mammary gland (Jakab et al.,
2008d). The immunohistochemical detection of claudin-
5 protein had a higher sensitivity than CD31, and vWf
antigen in case of canine hemangiosarcomas (Jakab et
al., 2009a). In the present study we detected that the
surface and crypt epithelial cells of the canine normal
colorectal mucosa and the neoplastic cells of the
CLGCC were negative for claudin-5 molecule, but the
endothelial cells of the normal vessels of the intact
colorectum and the intra- and peritumoural microvessels
showed intense claudin-5 positivity. 
Claudin-7 is expressed normally in the distal
nephron epithelium of the kidney (Li et al., 2004). This
protein is a novel immunohistochemical marker for renal
tumour classification. The distal nephron marker,
claudin-7, is overexpressed in human chromophobe
renal cell carcinoma versus oncocytoma and other
tumour subtypes (Hornsby et al., 2007). Claudin-7 may
play an important role in human immunodeficiency virus
(HIV) infection of CD4(-) cells. This protein can serve
as a receptor for HIV-1 infection of CD4(-) cells or as a
ligand on the viral envelope (Zheng et al., 2005). Human
studies have desrcibed that claudin-7 is overexpressed in
gastric dysplasia and adenocarcinoma but it is not in the
surrounding nonneoplastic epithelial cells. These results
suggest that claudin-7 expression is an early event in
gastric tumourigenesis and is maintained throughout
tumour progression (Johnson et al., 2005). The increased
expression of claudin-7 in HCRC cells leads to a loss of
polarization and to an increase of h-catenin/Tcf-4
activity and proliferation in colorectal cancer cells,
resulting in an enhancement of their tumorforming
ability in vivo (Darido et al., 2008). We reported
previously that claudin-7 is one of the integral
constituents of tight junction structures of canine normal
mammary gland (Jakab et al., 2008a) and canine primary
(Jakab et al., 2008d), secondary epithelial mammary
gland tumours (Jakab et al., 2009b). In our present study
we detected that the surface and crypt epithlial cells of
the canine normal colorectal mucosa showed a diffuse
lateral membranous pattern of staining for claudin-7 and
the CLGCC overexpressed this claudin protein. This
tight junction protein overexpressed in human squamous
cell carcinomas of the uterine cervix (Sobel et al., 2005),
as well as in the adenocarcinoma of the esophagus
(Montgomery et al., 2006). In contrast, it is
underexpressed in ductal carcinoma of the breast
(Kominsky et al., 2003). In this present study more than
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50 % of the CLGCCs showed a lateral membrane and
cytoplasmic positivity for claudin-7 molecule. Further
functional studies are needed to clarify the biological
role of mislocalisation of claudin-7 from the cell
membrane to the cytoplasm in canine low grade
carcinoma.
In conclusion, the results of the present study have
shown that claudin-1 is not expressed in the epithelium
of canine normal colorectal mucosa, but increased
expression of this protein is observed in CLGCCs.
Consequently, we hypothesize that claudin-1 plays a role
in the progression of canine colorectal carcinoma.
Further functional studies are needed to clarify the
biological role of the mislocalization of claudin-1
molecule from the cell membrane to the cytoplasm in
these histologic subtypes of canine colorectal tumour.
The canine intact colorectal epithelium showed diffuse
punctate positivity for claudin-3 and claudin-4
molecules, and the low grade colorectal cancer
overexpressed the claudin-3 protein. The CLGCCs
showed a lower claudin-4 expression and this result
suggests that reduced expression of claudin-4 molecule
may lead to cellular disorientation, detachment and
invasion of canine colorectal cancers. In the present
study we detected that the epithelial cells of the canine
normal colorectal mucosa and the neoplastic cells of the
CLGCCs were negative for claudin-5 molecule, but the
endothelial cells of the intact vessels, lymphatics and
intratumoural, peritumoural microvessels showed strong
claudin-5 positivity. This can help during light
microscopic analysis in the detection of lymphovascular
invasion of the colorectal cancer cells (claudin-5 positive
vessels, lymphpatics with claudin-5 negative tumour
emboli), as well as in the case of canine mammary gland
cancer intravasation (Jakab et al., 2008e). In addition,
claudin-5 can be used for the intra-, and peritumoural
microvessel density assessment of canine colorectal
cancers. The epithelial cells of the canine normal
colorectal mucosa showed a diffuse lateral membranous
positivity for claudin-7, and the CLGCCs overexpressed
this claudin. More than 50% of canine low grade cancer
showed a lateral membrane and cytoplasmic positivity
for claudin-7 molecule. Further functional studies are
needed to clarify the biological role of overexpression
and mislocalisation of claudin-7 in CLGCCs.
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